FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Marketing

FDA Sued Over Rejection of Supplement Ad Claims

Three Benesh Friedlander Coplan & Aronoff attorneys say a suit against FDA filed by the Alliance for Natural Health USA could change the way that supp...

latest-news-card-1
Biologics

Blood Donor Screening in an Ebola Outbreak

FDA publishes a guidance notifying blood establishments about agency recommendations for screening and deferring blood donors in response to an Ebola ...

latest-news-card-1
Human Drugs

Repeat CGMP Violations Seen in Excelvision Inspection

FDA warns Excelvision about CGMP violations in the production of drugs at its facility in Annonay, France.

latest-news-card-1
Human Drugs

Genzyme Ireland Inspection Documents CGMP Issue

FDA warns Genzyme Ireland about the failure of the firms quality control unit to ensure that drugs comply with CGMP requirements.

latest-news-card-1
Medical Devices

Abiomed Impella Heart Pump Recall is Class 1

FDA says the Abiomed recall of certain Impella CP Sets with SmartAssist is Class 1.

latest-news-card-1
Medical Devices

Insulet Omnipod Pod Recall is Class 1: FDA

FDA says an Insulet recall of specific lots of its Omnipod Pods is Class 1.

latest-news-card-1
Human Drugs

FDA Selects 7 PreCheck Pilot Participants

FDA selects seven companies from 80 applications to participate in the agencys PreCheck Pilot Program to advance U.S. drug manufacturing.

latest-news-card-1
Human Drugs

Next-Generation Sequencing Data Submission Guidance

FDA publishes a guidance on submitting next-generation sequencing data to CDERs Division of Antivirals.

latest-news-card-1
Human Drugs

FDA OKs Blood Cancer Drug Tregzi

FDA approves Orca Biosystems Tregzi to improve chronic graft-versus-host disease (GVHD)-free survival in adults with blood cancers undergoing allogene...

latest-news-card-1
Human Drugs

CGMP Issues at Indias Wizcure Pharmaa

FDA warns Indias Wizcure Pharmaa about CGMP violations in its production of over-the-counter drugs.